These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 10485483)
21. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages. Barrios-Rodiles M; Keller K; Belley A; Chadee K Biochem Biophys Res Commun; 1996 Aug; 225(3):896-900. PubMed ID: 8780708 [TBL] [Abstract][Full Text] [Related]
22. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway]. Huang DS; Xu X; Zheng SS; Cheng JF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041 [TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Tucker ON; Dannenberg AJ; Yang EK; Zhang F; Teng L; Daly JM; Soslow RA; Masferrer JL; Woerner BM; Koki AT; Fahey TJ Cancer Res; 1999 Mar; 59(5):987-90. PubMed ID: 10070951 [TBL] [Abstract][Full Text] [Related]
24. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825 [TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308 [TBL] [Abstract][Full Text] [Related]
26. Expression of cyclooxygenase 2 in human malignant melanoma. Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178 [TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912 [TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells. Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373 [TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949 [TBL] [Abstract][Full Text] [Related]
30. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. van Rees BP; Saukkonen K; Ristimäki A; Polkowski W; Tytgat GN; Drillenburg P; Offerhaus GJ J Pathol; 2002 Feb; 196(2):171-9. PubMed ID: 11793368 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153 [TBL] [Abstract][Full Text] [Related]